Prospective randomized phase-II trial of ipilimumab/nivolumab versus standard of care in non-clear cell renal cell cancer - results of the SUNNIFORECAST trial.
Saved in:
| Title: | Prospective randomized phase-II trial of ipilimumab/nivolumab versus standard of care in non-clear cell renal cell cancer - results of the SUNNIFORECAST trial. |
|---|---|
| Authors: | Bergmann, L.1 (AUTHOR) l.bergmann@em.uni-frankfurt.de, Albiges, L.2 (AUTHOR), Ahrens, M.1 (AUTHOR), Gross-Goupil, M.3 (AUTHOR), Boleti, E.4 (AUTHOR), Gravis, G.5 (AUTHOR), Fléchon, A.6 (AUTHOR), Grimm, M.-O.7 (AUTHOR), Bedke, J.8,9 (AUTHOR), Barthélémy, P.10 (AUTHOR), Castellano, D.11 (AUTHOR), Mellado, B.12 (AUTHOR), Ivanyi, P.13 (AUTHOR), Rottey, S.14 (AUTHOR), Flörcken, A.15 (AUTHOR), Suarez, C.16 (AUTHOR), Maroto, P.17 (AUTHOR), Grünwald, V.18 (AUTHOR), Oosting, S.F.19 (AUTHOR), Kopecky, J.20 (AUTHOR) |
| Source: | Annals of Oncology. Jul2025, Vol. 36 Issue 7, p796-806. 11p. |
| Database: | Academic Search Ultimate |
| ISSN: | 09237534 |
|---|---|
| DOI: | 10.1016/j.annonc.2025.03.016 |
